With the passing of the Inflation Reduction Act, significant changes are coming for drug pricing and payment in the United States. At the same time, the upcoming revision of the EU Pharma Package will have a significant impact on the competitiveness of the EU biopharmaceutical ecosystem for years to come.
Justin Duarte Pine of Biotechnology Innovation Organization, Benjamin Bradford of MassBio and EUCOPE’s Alexander Natz join our latest podcast to focus on trans-Atlantic innovation. They compare and contrast the EU and the US biopharma ecosystems and detail how we can work together to build bridges of innovation for life sciences.
Full episode can be found here: https://www.eucope.org/sounds-of-science-podcast-14-on-trans-atlantic-innovation/